Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01AFG
|
|||
| Former ID |
DNCL002642
|
|||
| Drug Name |
RG7414
|
|||
| Indication | Colorectal cancer [ICD-11: 2B91.Z] | Discontinued in Phase 2 | [1] | |
| Non-small-cell lung cancer [ICD-11: 2C25.Y] | Discontinued in Phase 2 | [1] | ||
| Company |
Genentech
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Epidermal growth factor-like protein 7 (EGFL7) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800030998) | |||
| REF 2 | Anti-EGFL7 antibodies enhance stress-induced endothelial cell death and anti-VEGF efficacy. J Clin Invest. 2013 September 3; 123(9): 3997-4009. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.